Trial
NCT03818997
Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Collaborators
Hoffmann-La Roche; Leap Therapeutics, Inc.
Condition
Esophageal Cancer
Intervention
DKN-01
Why stopped
Company decision
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-02-05